Factors of Occurrence of Amenorrhea and Climacteric Symptoms in Breast Cancer Patients Underwent Chemotherapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the factors of occurrence of amenorrhea and the severity of climacteric symptoms in breast cancer patients who underwent chemotherapy. Method: Women diagnosed with breast cancer without metastasis or recurrence, had surgery followed by chemotherapy, and had menses at the time of surgery were recruited from S hospital located in Seoul. A total of 99 women aged 31 thru 55 years participated and filled out a structured questionnaire including the Functional Assessment Cancer Therapy-Breast plus Endocrine Symptom when they visited the clinic for follow-up. Result: In 88 women amenorrhea occurred within an average of 2 months since beginning chemotherapy, and menstruation was resumed in only 11 women. About 98% of women aged over 40 experienced a cessation in menses thus age was an apparent factor of amenorrhea (Exp(B)=.76, p<.05). Presence of chronic disease (ß=.25, p<.05) and body weight change (ß=.30, p<.01) were significant factors influencing the severity of climacteric symptoms. Conclusion: Nurses need to have clinical evidences of menstrual changes due to breast cancer treatment. Information about premature menopause and climacteric symptoms should be provided according to women's health conditions so that they cope better during their survival.
Abstract
Purpose: This study aimed to investigate the factors of occurrence of amenorrhea and the severity of climacteric symptoms in breast cancer patients who underwent chemotherapy. Method: Women diagnosed with breast cancer without metastasis or recurrence, had surgery followed by chemotherapy, and had menses at the time of surgery were recruited from S hospital located in Seoul. A total of 99 women aged 31 thru 55 years participated and filled out a structured questionnaire including the Functional Assessment Cancer Therapy-Breast plus Endocrine Symptom when they visited the clinic for follow-up. Result: In 88 women amenorrhea occurred within an average of 2 months since beginning chemotherapy, and menstruation was resumed in only 11 women. About 98% of women aged over 40 experienced a cessation in menses thus age was an apparent factor of amenorrhea (Exp(B)=.76, p<.05). Presence of chronic disease (ß=.25, p<.05) and body weight change (ß=.30, p<.01) were significant factors influencing the severity of climacteric symptoms. Conclusion: Nurses need to have clinical evidences of menstrual changes due to breast cancer treatment. Information about premature menopause and climacteric symptoms should be provided according to women's health conditions so that they cope better during their survival.
참고문헌 (21)
- Bianco, A. R., "Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer", British J Cancer, 63, pp.799~803 (1991)
- Bines, J., "Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer", J Clin Oncol, 14(5), pp.1718~1729 (1996)
- Del Mastro, L., "Amenorrhea induced by adjuvant chemotherapy in early breast cancer patient: prognostic role and clinical implications", Breast Cancer Res Treat, 43, pp.183~190 (1997)
- Fallowfield, L. J., "Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptoms subscale for the FACT-B", Breast Cancer Res Treat, 55, pp.189~199 (1999)
- Fornier, M. N., "Incidence of chemotherapy-induced,long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane", Cancer, 104(8), pp.1575~1579 (2005)
- Ganz,P.A., "Breast cancer, menopause, and long-term survivorship: critical issue for the 21st century", Am J Med, 111(12B), pp.1365~1415 (2005)
- Ganz, P. A., "Breast cancer in younger women: reproductive and late health effects of treatment", J Clin Oncol, 21(22), pp.4184~4193 (2003)
- Ganz, P. A., "Life after breast cancer: understanding women's health-related quality of life and sexual functioning", J Clin Oncol, 16(2), pp.501~514 (1998)
- Goldhirsch, A., "The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients", The International Breast Cancer Study Group. Ann Oncol, 1, pp.183~188 (1990)
- Goodwin, P. J., "Risk of menopause during the first year after breast cancer diagnosis", J Clin Oncol, 17(8), pp.2365~2370 (1999)
- Gupta, P., "Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life", Climacteric, 9, pp.49~58 (2006)
- Korean Breast Cancer Society, "The breast" (2005), Iljogak
- Korean Breast Cancer Society, "Nationwide Korean breast cancer data of 2004 using breast cancer registration program", J Breast Cancer, 9(2), pp.151~161 (2006)
- Lee,K.H., "Postoperative morbidity, menopause symptoms, and quality of life in patients with breast cancer", 석사, pp.2006
- National Health Insurance Corporation, "Family Health guide" (2007), National Health Insurance Corporation
- Park, Y. J., "The menopausal age and climacteric symptoms, and the related factors of Korean women", Korean J Women Health Nurs, 7(4), pp.473~485 (2001)
- Partridge, A., "Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI", Eur J Cancer, 43, pp.1646~1653 (2007)
- Reh, A., "Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers", Fertil Steril, 86(3), pp.S97~S98 (2007)
- Tham, Y. L., "The rates of chemotherapyinduced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane", Am J Clin Oncol, 30(2), pp.126~132 (2007)
- Yun, M. R, "Menopausal symptoms and menstrual changes in breast cancer survivors treated with adjuvant chemotherapy", 석사, pp.2003